Interleukin 6 upregulates MCL-1 expression by a JAK/STAT3 pathway in cholangiocarcinoma cells

被引：0
|
作者：
Isomoto, H [1 ]
Kobayashi, S [1 ]
Werneburg, N [1 ]
Bronk, S [1 ]
Gores, G [1 ]
机构：
[1] Mayo Clin, Coll Med, Rochester, MN USA
来源：
HEPATOLOGY | 2005年 / 42卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：261A / 262A
页数：2
相关论文
共 50 条
  • [21] Luteolin Arrests Cell Cycling, Induces Apoptosis and Inhibits the JAK/STAT3 Pathway in Human Cholangiocarcinoma Cells
    Aneknan, Ploypailin
    Kukongviriyapan, Veerapol
    Prawan, Auemduan
    Kongpetch, Sarinya
    Sripa, Banchob
    Senggunprai, Laddawan
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (12) : 5071 - 5076
  • [22] A NOVEL SMALL MOLECULE, FLLL32 MAY BE THERAPEUTICALLY USEFUL FOR CHOLANGIOCARCINOMA BY INHIBITING CONSTITUTIVE JAK2/STAT3 SIGNALING AND MODULATING BOTH MCL-1 EXPRESSION AND MITOCHONDRIAL FUNCTION
    Kogure, Takayuki
    Braconi, Chiara
    Huang, Nianyuan
    Li, Cheng-long
    Park, Inhee
    Fuchs, James
    Schwartz, Eric B.
    Li, Pui-Kai
    Patel, Tushar
    HEPATOLOGY, 2009, 50 (04) : 1144A - 1144A
  • [23] Interleukin-22 upregulates FIB-EGF expression in HaCat cells via JAK2/STAT3 and ERK1/2 signaling
    Luo, S.
    Liu, X.
    Zheng, Y.
    Xu, W.
    Ni, H.
    Li, Y.
    Liu, Q.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 (08) : S5 - S5
  • [24] Interleukin-22 upregulates HB-EGF expression in HaCaT cells via JAK2/STAT3 and ERK1/2 signalling
    Luo, Suju
    Liu, Xinxin
    Zheng, Yan
    Xu, Wenjuan
    Ni, Haiyang
    Li, Yan
    Liu, Quanzhong
    EXPERIMENTAL DERMATOLOGY, 2015, 24 (09) : 713 - 714
  • [25] Death of multiple myeloma cells induced by cAMP-signaling involves downregulation of Mcl-1 via the JAK/STAT pathway
    Follin-Arbelet, Virginie
    Torgersen, Maria Lyngaas
    Naderi, Elin Hallan
    Misund, Kristine
    Sundan, Anders
    Blomhoff, Heidi Kiil
    CANCER LETTERS, 2013, 335 (02) : 323 - 331
  • [26] Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression
    Epling-Burnette, PK
    Liu, JH
    Catlett-Falcone, R
    Turkson, J
    Oshiro, M
    Kothapalli, R
    Li, YX
    Wang, JM
    Yang-Yen, HF
    Karras, J
    Jove, R
    Loughran, TP
    JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (03): : 351 - 361
  • [27] Anlotinib Inhibits Cisplatin Resistance in Non-Small-Cell Lung Cancer Cells by Inhibiting MCL-1 Expression via MET/STAT3/Akt Pathway
    Wang, Lile
    Xu, Lu
    Han, Shuhua
    Zhu, Xiaoli
    CANADIAN RESPIRATORY JOURNAL, 2024, 2024
  • [28] Chrysin overcomes TRAIL resistance of cancer cells through Mcl-1 downregulation by inhibiting STAT3 phosphorylation
    Lirdprapamongkol, Kriengsak
    Sakurai, Hiroaki
    Abdelhamed, Sherif
    Yokoyama, Satoru
    Athikomkulchai, Sirivan
    Viriyaroj, Amornrat
    Awale, Suresh
    Ruchirawat, Somsak
    Svasti, Jisnuson
    Saiki, Ikuo
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 43 (01) : 329 - 337
  • [29] Bufadienolide compounds sensitize human breast cancer cells to TRAIL-induced apoptosis via inhibition of STAT3/Mcl-1 pathway
    Yinhui Dong
    Shutao Yin
    Jinghua Li
    Cheng Jiang
    Min Ye
    Hongbo Hu
    Apoptosis, 2011, 16 : 394 - 403
  • [30] Bufadienolide compounds sensitize human breast cancer cells to TRAIL-induced apoptosis via inhibition of STAT3/Mcl-1 pathway
    Dong, Yinhui
    Yin, Shutao
    Li, Jinghua
    Jiang, Cheng
    Ye, Min
    Hu, Hongbo
    APOPTOSIS, 2011, 16 (04) : 394 - 403
12345